A citation-based method for searching scientific literature




G Parmigiani, D Berry, O Aguilar. Am J Hum Genet 1998
Times Cited: 491




List of shared articles



Times cited

Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
Melissa K Frey, Rohini V Kopparam, Zhen Ni Zhou, Jessica C Fields, Ama Buskwofie, Ann D Carlson, Thomas Caputo, Kevin Holcomb, Eloise Chapman-Davis. Cancer 2019
4

A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.
Ana F Best, Margaret A Tucker, Megan N Frone, Mark H Greene, June A Peters, Hormuzd A Katki. Cancer Epidemiol Biomarkers Prev 2019
3

Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer.
Ava Willoughby, Paul R Andreassen, Amanda Ewart Toland. J Pers Med 2019
12


Implementing a Population-Based Breast Cancer Risk Assessment Program.
Erica Silver, Neil Wenger, Zhuoer Xie, David Elashoff, Kristina Lee, Lisa Madlensky, Jacqueline Trent, Antonia Petruse, Liliana Johansen, Arash Naeim. Clin Breast Cancer 2019
2

Evaluating BRCA mutation risk predictive models in a Chinese cohort in Taiwan.
Fei-Hung Hung, Yong Alison Wang, Jhih-Wei Jian, Hung-Pin Peng, Ling-Ling Hsieh, Chen-Fang Hung, Max M Yang, An-Suei Yang. Sci Rep 2019
2

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019
21